NO20075199L - Treatment or prevention of pruritus - Google Patents

Treatment or prevention of pruritus

Info

Publication number: NO20075199L
Authority: NO; Norway
Prior art keywords: pruritus; treatment; prevention; oxaprozin; medicaments
Prior art date: 2005-03-30

Application number

NO20075199A

Other languages

English (en)

Norwegian (no)

Inventor

Morten Sloth Weidner

Original Assignee

Astion Pharma As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-30

Filing date

2007-10-11

Publication date

2008-01-02

2007-10-11 Application filed by Astion Pharma As filed Critical Astion Pharma As

2008-01-02 Publication of NO20075199L publication Critical patent/NO20075199L/no

Links

208000003251 Pruritus Diseases 0.000 title abstract 3
230000002265 prevention Effects 0.000 title 1
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
OFPXSFXSNFPTHF-UHFFFAOYSA-N oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 abstract 1
229960002739 oxaprozin Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000007910 systemic administration Methods 0.000 abstract 1
238000011200 topical administration Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicinal Preparation (AREA)

NO20075199A 2005-03-30 2007-10-11 Treatment or prevention of pruritus NO20075199L (no)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
DKPA200500437		2005-03-30
DKPA200500438		2005-03-30
US69477405P	2005-06-27	2005-06-27
DKPA200500948		2005-06-27
DKPA200500949		2005-06-27
US69504005P	2005-06-28	2005-06-28
PCT/DK2006/000180 WO2006102899A2 (en)	2005-03-30	2006-03-30	Oxaprozin or closely related compound for the treatment and prevention of

Publications (1)

Publication Number	Publication Date
NO20075199L true NO20075199L (no)	2008-01-02

Family

ID=36215671

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO20075199A NO20075199L (no)	2005-03-30	2007-10-11	Treatment or prevention of pruritus
NO20075218A NO20075218L (no)	2005-03-30	2007-10-12	Dermatological compositions and salts for the treatment of dermatological diseases
NO20075227A NO20075227L (no)	2005-03-30	2007-10-12	Treatment of eczemas

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
NO20075218A NO20075218L (no)	2005-03-30	2007-10-12	Dermatological compositions and salts for the treatment of dermatological diseases
NO20075227A NO20075227L (no)	2005-03-30	2007-10-12	Treatment of eczemas

Country Status (12)

Country	Link
EP (3)	EP1707201A1 (es)
JP (3)	JP2008534526A (es)
KR (3)	KR20080011280A (es)
AU (3)	AU2006228869A1 (es)
BR (3)	BRPI0607648A2 (es)
CA (3)	CA2603300A1 (es)
EA (3)	EA200702026A1 (es)
EC (3)	ECSP077845A (es)
IL (3)	IL186021A0 (es)
MX (3)	MX2007012051A (es)
NO (3)	NO20075199L (es)
WO (3)	WO2006102898A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0821537D0 (en) *	2008-11-25	2008-12-31	Union Life Sciences Ltd	Therapeutic target
WO2017045081A1 (en) *	2015-09-18	2017-03-23	Delivra Inc.	Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions
WO2018031529A1 (en) *	2016-08-08	2018-02-15	Avedro, Inc.	Systems and methods for cross-linking treatments of an eye
CN110035749B (zh)	2016-10-25	2022-11-15	蒂库尔有限公司	Fabp4作为皮肤病中的治疗靶
CA3083786A1 (en) *	2017-12-07	2019-06-13	Dermavant Sciences GmbH	Topical ointment formulations of pde-4 inhibitor and their use in treating skin conditions
RU2685436C1 (ru) *	2018-06-22	2019-04-18	ЗАО "ФармФирма "Сотекс"	Трансдермальный препарат для лечения и профилактики болезней суставов и мягких тканей
JP7514598B2 (ja) *	2018-12-20	2024-07-11	小林製薬株式会社	皮膚外用組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE32084B1 (en)	1967-06-07	1973-04-04	Wyeth John & Brother Ltd	Thiazole derivatives
US3578671A (en) *	1967-11-06	1971-05-11	Wyeth John & Brother Ltd	Oxazoles
IE52909B1 (en) *	1981-04-28	1988-04-13	Wyeth John & Brother Ltd	Oxazole derivatives
US4659728A (en)	1985-02-25	1987-04-21	American Home Products Corporation	Hydroxy substituted 4,5-diphenyl-2-oxazole propanoic acid
EP0270316A3 (en) *	1986-12-04	1989-12-06	Pfizer Inc.	Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US5380738A (en)	1993-05-21	1995-01-10	Monsanto Company	2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6090834A (en) *	1993-05-21	2000-07-18	G.D. Searle & Co.	Substituted oxazoles for the treatment of inflammation
WO1995011017A1 (en)	1993-10-20	1995-04-27	The Boots Company Plc	Ibuprofen and flurbiprofen as anti-pruritic agents
JPH07316075A (ja)	1994-05-26	1995-12-05	Pola Chem Ind Inc	皮膚外用剤
GB9606429D0 (en)	1996-03-27	1996-06-05	Boots Co Plc	Pharmaceutical compositions
BR9710448A (pt) *	1996-05-20	1999-08-17	Searle & Co	Formula-{es farmac-uticas de sal de pot ssio sÄdioe tris oxaprozina
US5976566A (en) *	1997-08-29	1999-11-02	Macrochem Corporation	Non-steroidal antiinflammtory drug formulations for topical application to the skin
IL142037A0 (en) *	2001-03-15	2002-03-10	Agis Ind 1983 Ltd	Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
WO2005009342A2 (en)	2003-07-16	2005-02-03	Pharmacia Corporation	Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050232957A1 (en)	2004-04-14	2005-10-20	Katz Kenneth A	Compositions and methods for moisturizing skin

2006
- 2006-03-29 AU AU2006228869A patent/AU2006228869A1/en not_active Abandoned
- 2006-03-30 WO PCT/DK2006/000178 patent/WO2006102898A2/en not_active Ceased
- 2006-03-30 EP EP06112009A patent/EP1707201A1/en not_active Withdrawn
- 2006-03-30 BR BRPI0607648-3A patent/BRPI0607648A2/pt not_active Application Discontinuation
- 2006-03-30 JP JP2008503366A patent/JP2008534526A/ja active Pending
- 2006-03-30 BR BRPI0609535-6A patent/BRPI0609535A2/pt not_active Application Discontinuation
- 2006-03-30 CA CA002603300A patent/CA2603300A1/en not_active Abandoned
- 2006-03-30 EP EP06112006A patent/EP1707199A1/en not_active Withdrawn
- 2006-03-30 JP JP2008503367A patent/JP2008534527A/ja active Pending
- 2006-03-30 WO PCT/DK2006/000180 patent/WO2006102899A2/en not_active Ceased
- 2006-03-30 BR BRPI0609653-0A patent/BRPI0609653A2/pt not_active IP Right Cessation
- 2006-03-30 CA CA002605121A patent/CA2605121A1/en not_active Abandoned
- 2006-03-30 EA EA200702026A patent/EA200702026A1/ru unknown
- 2006-03-30 EA EA200702027A patent/EA200702027A1/ru unknown
- 2006-03-30 EA EA200702023A patent/EA200702023A1/ru unknown
- 2006-03-30 JP JP2008503368A patent/JP2008534528A/ja active Pending
- 2006-03-30 KR KR1020077025181A patent/KR20080011280A/ko not_active Withdrawn
- 2006-03-30 KR KR1020077025180A patent/KR20080005526A/ko not_active Withdrawn
- 2006-03-30 AU AU2006228870A patent/AU2006228870A1/en not_active Abandoned
- 2006-03-30 WO PCT/DK2006/000181 patent/WO2006102900A1/en not_active Ceased
- 2006-03-30 CA CA002603297A patent/CA2603297A1/en not_active Abandoned
- 2006-03-30 KR KR1020077025179A patent/KR20080005525A/ko not_active Withdrawn
- 2006-03-30 MX MX2007012051A patent/MX2007012051A/es not_active Application Discontinuation
- 2006-03-30 MX MX2007012050A patent/MX2007012050A/es not_active Application Discontinuation
- 2006-03-30 AU AU2006228871A patent/AU2006228871A1/en not_active Abandoned
- 2006-03-30 EP EP06112007A patent/EP1707200A1/en not_active Withdrawn
- 2006-03-30 MX MX2007012052A patent/MX2007012052A/es not_active Application Discontinuation
2007
- 2007-09-18 IL IL186021A patent/IL186021A0/en unknown
- 2007-09-18 IL IL186020A patent/IL186020A0/en unknown
- 2007-09-18 IL IL186022A patent/IL186022A0/en unknown
- 2007-10-11 NO NO20075199A patent/NO20075199L/no not_active Application Discontinuation
- 2007-10-12 NO NO20075218A patent/NO20075218L/no not_active Application Discontinuation
- 2007-10-12 NO NO20075227A patent/NO20075227L/no not_active Application Discontinuation
- 2007-10-29 EC EC2007007845A patent/ECSP077845A/es unknown
- 2007-10-29 EC EC2007007846A patent/ECSP077846A/es unknown
- 2007-10-29 EC EC2007007843A patent/ECSP077843A/es unknown

Also Published As

Publication number	Publication date
EA200702027A1 (ru)	2008-02-28
WO2006102898A3 (en)	2006-12-28
EP1707199A1 (en)	2006-10-04
MX2007012050A (es)	2008-03-11
WO2006102900A1 (en)	2006-10-05
BRPI0609535A2 (pt)	2010-04-13
IL186021A0 (en)	2008-02-09
WO2006102899A2 (en)	2006-10-05
CA2605121A1 (en)	2006-10-05
NO20075227L (no)	2007-12-09
IL186022A0 (en)	2008-02-09
WO2006102899A3 (en)	2006-12-28
JP2008534526A (ja)	2008-08-28
EA200702026A1 (ru)	2008-04-28
KR20080005526A (ko)	2008-01-14
EP1707200A1 (en)	2006-10-04
MX2007012051A (es)	2008-02-22
EP1707201A1 (en)	2006-10-04
WO2006102898A2 (en)	2006-10-05
BRPI0607648A2 (pt)	2009-09-22
ECSP077843A (es)	2008-02-20
IL186020A0 (en)	2008-01-20
NO20075218L (no)	2007-12-27
JP2008534528A (ja)	2008-08-28
AU2006228869A1 (en)	2006-10-05
CA2603300A1 (en)	2006-10-05
JP2008534527A (ja)	2008-08-28
EA200702023A1 (ru)	2008-04-28
CA2603297A1 (en)	2006-10-05
KR20080005525A (ko)	2008-01-14
MX2007012052A (es)	2008-02-22
AU2006228870A1 (en)	2006-10-05
KR20080011280A (ko)	2008-02-01
ECSP077846A (es)	2008-02-20
BRPI0609653A2 (pt)	2010-04-20
AU2006228871A1 (en)	2006-10-05
ECSP077845A (es)	2008-02-20

Legal Events

Date	Code	Title	Description
2009-10-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20074999L (no)	2007-12-03	Metode og preparat for behandling av perifere vaskulaere sykdommer
EA200971053A1 (ru)	2010-06-30	Способы лечения кожных язв
NO20080745L (no)	2008-04-09	Nye peptider for anvendelse i behandling av fedme
NO20075199L (no)	2008-01-02	Treatment or prevention of pruritus
WO2009050506A3 (en)	2009-11-26	Combination 059
EA200801580A1 (ru)	2009-02-27	Новые производные пирониндола и способ их получения
NO20082790L (no)	2008-09-16	Behandling av type 2 diabetes med en kombinasjon av DPIV inhibitor og metformin eller thiazolidindion
DE502005010615D1 (de)	2011-01-13	Mittel zur behandlung von entzündlichen erkrankungen
CR9949A (es)	2009-07-23	Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
MX2009006327A (es)	2009-06-23	Compuestos heterociclicos y metodos de uso de los mismos.
ATE529113T1 (de)	2011-11-15	Salze von kalium-atp-kanal-öffnern und ihre verwendungen
EA201100621A1 (ru)	2011-12-30	Лечение диабета у пациентов, у которых наблюдается недостаточный гликемический контроль несмотря на лечение пероральным или непероральным противодиабетическим лекарственным средством
ATE416177T1 (de)	2008-12-15	Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
BR0308928A (pt)	2005-01-04	Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
EA201490004A1 (ru)	2014-09-30	Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей
ATE457729T1 (de)	2010-03-15	Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie
EA201490254A1 (ru)	2014-07-30	Комбинированное лечение гепатита с
EA200802223A1 (ru)	2009-06-30	1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
WO2009068659A3 (en)	2009-08-06	Novel disease treatment by predicting drug association
ATE453642T1 (de)	2010-01-15	Substituierte phenylaminopyrimidine
NO20064186L (no)	2006-11-14	Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
NO20076405L (no)	2008-02-11	Anvendelse av 24-nor-UDCA
ATE543492T1 (de)	2012-02-15	Behandlung von lungenkrebs
CY1109666T1 (el)	2014-08-13	Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
WO2006108679A3 (en)	2007-02-22	Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer